222 related articles for article (PubMed ID: 12629860)
21. Cutaneous Pseudolymphomas.
Romero-Pérez D; Blanes Martínez M; Encabo-Durán B
Actas Dermosifiliogr; 2016 Oct; 107(8):640-51. PubMed ID: 27289134
[TBL] [Abstract][Full Text] [Related]
22. Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation.
Navarrete-Dechent C; Del Puerto C; Abarzúa-Araya Á; Molgó M; Geller S; Andreani S; Cury-Martins J; Sanches JA; Montoya J; González S; Uribe P
Int J Dermatol; 2019 Nov; 58(11):1270-1276. PubMed ID: 31347153
[TBL] [Abstract][Full Text] [Related]
23. Cutaneus pseudolymphoma: a case report.
Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A
In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Mitteldorf C
Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous pseudolymphomas.
Ploysangam T; Breneman DL; Mutasim DF
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):877-95; quiz 896-7. PubMed ID: 9631994
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Merkel cell polyomavirus DNA in cutaneous lymphomas, pseudolymphomas, and inflammatory skin diseases.
Andres C; Puchta U; Sander CA; Ruzicka T; Flaig MJ
Am J Dermatopathol; 2010 Aug; 32(6):593-8. PubMed ID: 20534985
[TBL] [Abstract][Full Text] [Related]
27. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
Han B; Liu H; Wang H
Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
[TBL] [Abstract][Full Text] [Related]
28. A nodular syphilid presenting as a pseudolymphoma: mimicking a cutaneous marginal zone B-cell lymphoma.
Moon HS; Park K; Lee JH; Son SJ
Am J Dermatopathol; 2009 Dec; 31(8):846-8. PubMed ID: 19786852
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
Rijlaarsdam JU; Willemze R
Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
[TBL] [Abstract][Full Text] [Related]
30. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
31. [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas].
Smolle J; Kaudewitz P; Aberer E; Torne R; Burg G; Kerl H
Hautarzt; 1987 Aug; 38(8):461-6. PubMed ID: 3308776
[TBL] [Abstract][Full Text] [Related]
32. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
33. [Cutaneous pseudolymphomas and pseudoclonality of lymphoid infiltrates].
Quatresooz P; Piérard-Franchimont C; Devillers C; Piérard GE
Rev Med Liege; 2009 Nov; 64(11):581-6. PubMed ID: 20069973
[TBL] [Abstract][Full Text] [Related]
34. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
Starz H; Balda BR; Bachter D; Büchels H; Vogt H
Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous B-cell lymphomas.
Prince HM; Yap LM; Blum R; McCormack C
Clin Exp Dermatol; 2003 Jan; 28(1):8-12. PubMed ID: 12558619
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous B-cell lymphomas. Current concepts. I.
Santucci M; Pimpinelli N
Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous pseudolymphoma of the breast with late homozonal relapse.
Pecorari P; Rizzardi C; Melato M
Oncol Rep; 2001; 8(4):913-5. PubMed ID: 11410809
[TBL] [Abstract][Full Text] [Related]
38. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies.
Böer A; Tirumalae R; Bresch M; Falk TM
Br J Dermatol; 2008 Aug; 159(2):394-402. PubMed ID: 18547309
[TBL] [Abstract][Full Text] [Related]
39. [Cutaneous B-cell lymphoma].
Cortés B; Prins C
Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
[TBL] [Abstract][Full Text] [Related]
40. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
